Pharmaceutical Company
Intellectual property, data exclusivity and patent eligibility, generally;
CREATES Act of 2019 (S.340)/(H.R.965);
Preserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375);
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374);
Affordable Prescriptions for Patients Act (S.1416);
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3391);
Affordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398);
Protecting Consumer Access to Generic Drugs Act (H.R. 1499). FDA - rare and orphan disease issues; 
Prescription drug coverage and payment policies; 
Medical innovation issues.
CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
ANDREA LARUE ANDREA LARUE LISA GERMAN FOSTER